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EpidemiologyBackground:Malaria parasiteswithin an individual infection often consist ofmultiple strains (clonal populations)
of a single species,which have the potential to interact bothwith one another, andwith the host immune system.
Several effects of these interactions have beenmeasured in different parasite systems including competition and
mutualism; however, direct observation of these effects in human malaria has been limited by sampling
complexities and inherent ethical limitations.
Methods: Using multiple complementary epidemiological models, we propose a suite of analyses to more fully
utilize data from challenge experiments, and re-examine historical human challenge studies with mixed-strain
Plasmodium vivax inocula. We then compare these results with murine model systems using mixed-strain
Plasmodium yoelii or Plasmodium chabaudi, to explore the utility of these methods in fully utilizing these data,
including the ﬁrst quantitative estimates of effect sizes for mixed-strain parasitemia. These models also provide
a method to assess consistency within these animal model systems.
Results: We ﬁnd that amongst a limited set of P. vivax (incubation time) and P. yoelii infections (time-to-
mortality), survival times at a study population-level are intermediate between each single-clone infection,
and are not dominated by the more virulent clone; in P. vivax relapses, mixed clone infections also show
intermediate survival curves. In these infections, the results strongly suggest that highly virulent clones have
their virulence attenuated by the presence of less-virulent clones. The analysis of multiple experiments with
P. chabaudi suggests greater nuances in the interactions between strains, and that mortality and time-to-event
in mixed-strain infections are both indistinguishable from single infections with the more virulent strain.
Conclusions: These divergent dynamics support earlier work that suggested drivers of virulence may differ in
fundamental ways between malaria species that are reticulocyte-speciﬁc and those that readily infect all red
blood cell stages which should be studied in greater detail. The effect sizes (magnitude of biological effects)
from these analyses are signiﬁcant, and suggest the potential for important gains in malaria control by greater
incorporation of evolutionary epidemiology theory. Moreover, we suggest that using these epidemiological
models may generally allow fuller use of data from experimentally challenging animal model experiments.
© 2015 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY license
(http://creativecommons.org/licenses/by/4.0/).1. Introduction
Malaria is a major contributor to morbidity and mortality globally,
with an estimated 198 million cases (95% CI: 124 to 283) and
584,000 deaths (95% CI: 367,000 to 755,000) in 2013 (World Health
Organization, 2014). There are ﬁve species that generally infect
humans, and the interactions between different species within a single
infection can have important clinical implications (Zimmerman et al.,
2004). Moreover, infections within an individual may be composed of.Lover@ucsf.edu (A.A. Lover),
. This is an open access article undermultiple strains (clonal populations) of a single species, which may
interact both with one another and with the host immune system
(Alizon et al., 2011).
The impacts of these interactive parasite populations have been
explored through multiple lines of research using two complementary
approaches: mathematical/statistical models, and experimental animal
systems. The interactions between parasite populations may lead to
parasite competition or to parasite mutualism; to the evolution of
virulence and drug susceptibility; and may facilitate genetic exchange
within infections (Balmer and Tanner, 2011). Moreover, these assem-
blages of hosts andmultiple parasites form an evolutionary community,
and the incorporation of ecological and evolutionary theory (Alizon
et al., 2009; Rigaud et al., 2010), has lead to the development ofthe CC BY license (http://creativecommons.org/licenses/by/4.0/).
83A.A. Lover, R.J. Coker / Infection, Genetics and Evolution 36 (2015) 82–91evolutionary epidemiology as aﬁeld in itself (Restif, 2009). However the
impacts of these parasite interactions on the host are highly variable,
and observed virulence in mixed-strain infections ranges along a con-
tinuum from being greater than the more virulent parasite; less than
the least virulent strain; or any intermediate virulence between these
extremes (Alizon et al., 2013).
In most epidemiological settings, the majority of individual Plasmo-
dium vivax and Plasmodium falciparum infections are composed of
multiple strains e.g., (Henry-Halldin et al., 2011; Juliano et al., 2010),
and these infections may represent an underutilized tool to explore
complex transmission dynamics (Bordes and Morand, 2009; de Araujo
et al., 2012). However, the inherent difﬁculties of data capture across
multiple spatial and temporal scales, and practical limitations in data
collection from parasitized hosts in natural environments have led to
suggestions for increased multidisciplinary research including the use
of more diverse methodologies to triangulate ﬁndings across different
specializations (Restif et al., 2012).
This work aims to address three speciﬁc questions: i) how can a
broader range of analytical approaches contribute to what is known
about mixed-strain infections with Plasmodium and within-host
dynamics?; ii) are results from the limited human challenge studies
consistent with what is known from murine model systems?; and iii)
do these results support any speciﬁc drivers of virulence?Fig. 1. Kaplan–Meier curves comparing incubation periods in single strains and mixed-
strain infections in human challenge experiments with Plasmodium vivax (Dataset I;
N = 184).1.1. Strain theory and virulence
The concept of parasite ‘strains’ is pervasive throughout themedical
and malaria literature, however, no consensus has emerged on what
these clinical isolates represent (Balmer and Tanner, 2011; McKenzie
et al., 2008); in general they refer to clonal or at least closely-related
populations.
While results have not been entirely consistent, themes have
emerged that appear to be general across parasite and host species
(Alizon et al., 2013). Observational data suggest that clones may
manifest with diverse clinical impacts, including differences in viru-
lence, clinical severity, transmissibility, and both the number and spac-
ing of hypnozoite-derived relapses in P. vivax infections (reviewed in
McKenzie et al., 2008). Recent molecular and genetic approaches have
added to this knowledge base by characterizing both inter- and intra-
host infections; these studies suggest that while many strains/isolates
represent a diversity of clonal populations, they generally produce
stable clinical and immunological responses (McKenzie et al., 2008).
Moreover, consideration of virulence metrics across the entire duration
of infection is critical to understand the pressures that drive strain
selection (Barclay et al., 2014).
Virulence in malaria infections is a composite outcome of at least
three processes: speciﬁc hematological impacts; host immune re-
sponse to toxins (including hemozoin and other parasitic debris);
and cyto-adhesion in some parasite species including P. falciparum
(reviewed in Mackinnon and Read, 2004; Wassmer et al., 2015). As-
sessments of the relative impact of these divergent processes have
been the subject of many experimental studies, and new modeling
approaches have been developed to disentangle the speciﬁc physio-
logical processes behind the composite endpoint of ‘virulence’
(Metcalf et al., 2011). These and related studies suggest that the rel-
ative contribution of each of these facets of observed virulence can
vary dramatically during the time course of an infection in a strain-
speciﬁc manner (Metcalf et al., 2012).
As noted by Alizon and coworkers, theoretical models almost
universally deﬁne virulence as an increase in host mortality, but in the
broader parasitology literature virulence is considered to be any harm
caused by a parasite that negatively impacts host ﬁtness (Alizon et al.,
2013). While a range of deﬁnitions have appeared (Casadevall and
Pirofski, 2001; Poulin and Combes, 1999), herein we consider it as ‘par-
asite populations that maximally exploit host resources’ to capture therange of endpoints examined in this study, with a focus on direct
parasite-induced mortality.
1.2. Previous analytical strategies
In general, previous analyses of murine systems have focused on
pooled hematological or parasitological outcomes as proxies for viru-
lence (comparing means or geometric means from all surviving ani-
mals) e.g., (Bell et al., 2006), but full multivariate analyses of outcomes
or explicit consideration of times-to-events have received very limited
attention. In the original analysis of Bell et al., differences between
single- and mixed-strain infections were not examined; virulence was
assessed by maximum anemia and parasitemia and showed broad
trends, but with complex relationships between the two metrics
[e.g., Fig. 1 in (Bell et al., 2006)].
Moreover, while time itself is a critical component of virulence (Day,
2002), analyses have generally focused on analysis at several (potential-
ly arbitrary) time points. In many cases, censoring of subjects has not
been considered — that is, animals are simply removed from analysis;
beyond a potential for introducing biases, this greatly reduces the
power of the analysis (Rothman et al., 2008). Finally, most parasitolog-
ical studies report only p-values to evaluate signiﬁcance, as is the norm
in ecology; however, these do not allow consideration of the effect sizes.
That is, statistically signiﬁcant effects may not be clinically or biological-
ly important- or as well-phrased by others, “Identifying biological im-
portance is what all biologists are ultimately aiming for, not the
identiﬁcation of statistical signiﬁcance.” (Nakagawa and Cuthill, 2007).
Although one prior study measured the statistical signiﬁcance of viru-
lence (Taylor et al., 1998), we are unaware of any prior effect size
estimates.
2. Materials and methods
The human study data (Dataset I; Table 1) in this analysis was ob-
tained during a series of rigorous challenge experiments in prison vol-
unteers during the 1940s–50s in an antimalarial drug development
program; all case-patients were malaria-naïve white males. Infections
were via mosquito challenge, there was complete follow-up, and pa-
tients were protected from superinfection due to the institutional na-
ture of this population. The study population (Table 1) includes a less-
virulent historical strain from North America and a highly virulent
clone from Papua New Guinea (Collins, 2013; Ungureanu et al., 1976).
Full details for human challenge infections including search criteria
and primary references were previously published (Lover and Coker,
2013); mixed-strain challenges can be found in (Cooper et al., 1950).
Table 1
Study population for historical human challenge experiments with Plasmodium vivax
(Dataset I).
End point Treatment n % of total
Incubation period Mixed 9 4.9
Chesson 131 71.2
St. Elizabeth 44 23.9
Total 184 100.0
Time-to-ﬁrst relapse Mixed 9 13.6
Chesson 19 28.8
St. Elizabeth 38 57.6
Total 66 100.0
Table 3
Study population for murine challenge experiments with Plasmodium chabaudi (Dataset
III) (Snounou et al., 1992).
Treatment n % of total Mortality % (95% CI)
AS 10 10 20 (2.5–55.6)
CB 10 10 80 (44.4–97.5)
DS 10 10 60 (26.2–87.8)
AS + CB 10 10 100 (69.2–100)
CB + DS 10 10 100 (69.2–100)
AS + CB 10 10 40 (12.2–73.8)
Total 60 100.0 –
Table 4
Study population for murine challenge experiments with Plasmodium chabaudi (Dataset
IV) (Bell et al., 2006).
Treatment n % of total Mortality % (95% CI)
1. AS 10 10 0 (0–30.8)
2. AJ 10 10 70 (34.8–93.3)
3. AT 10 10 30 (6.7–65.2)
4. CB 5 5 60 (14.7–94.7)
5. AS + AJ 10 10 30 (6.7–65.2)
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single-strain infections had symptomatic-only treatment with quinine;
and all mixed-strain inoculations had chloroquine exposure after the
primary attack.
Data for P. yoelii infections (Dataset II; Table 2) were extracted from
(Hargreaves et al., 1975); although the authors refer to these parasites
as Plasmodium berghei yoelii, a later revision elevated these to the
species-level as P. yoelii (Killick-Kendrick, 1974; Perkins et al., 2007).
CF1 mice were inoculated with 106 parasitized RBCs, and 2 × 106 in
the mixed infections. The mild strain of ‘17X’ was obtained from a
wild thicket rat; the virulent form was obtained after serial passages
in rodents and Anopheles stephensi (Hargreaves et al., 1975).
Data for the ﬁrst set of P. chabaudi murine challenge experiments
(Dataset III; Table 3) were taken from (Snounou et al., 1992). Male
CBA/ca mice were inoculated with 104 parasitized erythrocytes; mixed
infections were inoculated with 1 × 104 of each strain. Data for the
later murine challenges with P. chabaudi (Dataset IV; Table 4) are
from the work of Bell et al. and are available from the Drydad data
repository (Bell et al., 2014; de Roode et al., 2005). In these infections,
C57BL/6J inbred female mice were inoculated with 106 parasites;
mixed infections received a total dose of 2 × 106; prior work suggests
no impact of this 2-fold difference (Bell et al., 2006). The strains were
chosen speciﬁcally to mimic the potential diversity within wild parasite
populations. Our analysis was focused on the initial acute phase of pri-
mary infections before speciﬁc immunological responses occur; there-
fore surviving mice were censored one day past the last recorded
fatality (on day 15).
2.1. Ethics
This study analyzes fully de-identiﬁed, secondary data published in
the open literature and in the public domain; no ethics review was re-
quired. There has been prior detailed discussion about ethical aspects
of the analysis of data from the prison volunteers in these studies
(Harcourt, 2011; Weijer, 1999).
2.2. Methods
Preliminary analyses of the relationship between parasite strains
and times-to-event used non-parametric analyses (Kaplan–Meier
curves); differences were compared using the Peto–Peto test due to
differences in censoring and non-proportional hazards (Klein and
Kleinbaum, 2005; Lachin, 2011). Following this, multivariate analysis
(survival and/or log binomial models for time-to-event or mortality)Table 2
Study population for murine challenge experiments with Plasmodium yoelii (Dataset II).
Treatment n % of total Mortality % (95% CI)
Mixed 6 33.3 100 (54.1–100)
‘17X mild’ 6 33.3 50 (11.8–88.2)
‘17X virulent’ 6 33.3 100 (54.1–100)
Total 18 100.0 –was used to estimate the magnitude of observed effects. Parametric
and semi-parametric survival models were explored in the analysis of
these experimental data; extensive issues were observed with lack-of-
ﬁt, non-convergence due to collinear strains, crossing survival curves,
or complete separation. Moreover, standard survival models are not
applicable in the presence of crossing survival curves (Li et al., 2015).
Due to these analytical issues, a set of complementary analyses was
performed to allow all the studies to be analyzedwithin a consistent an-
alytical framework. First, pseudovalues were computed and used to
compare differences in restricted mean survival times (Parner and
Andersen, 2010; Andersen and Perme, 2010); thesemethods speciﬁcal-
ly assess differences when hazard ratiosmay be inaccurate; the restrict-
ed mean survival times (RMSTs) were calculated at just before the last
observed event time (symbolized as t*) (Royston and Parmar, 2011).
Secondly, the incidence rate ratios (that is, the ratio of total number of
events per follow-up time per strain) were compared.
Finally, where possible, full multivariate methods were to assess the
magnitude (effect size) of strain differences. For the study of P. yoelii
mortality (Dataset II), ﬂexible parametric survival models were used;
these are comprehensive alternatives to standard Cox survival models
which allow greater ﬂexibility in both model-ﬁtting and prediction
(Royston and Lambert, 2011; Royston and Parmar, 2002).
For the ﬁrst study of P. chabaudi mortality (Dataset III) regressions
for a binomial outcome (mortality) were used to quantify the differ-
ences in mortality between strains as times-to-event was not reported.
Due to very highmortality, logistic regressionmodels performed poorly.
Alternative models (log-binomial and so-called robust Poisson models)
were used and provided comparable estimates; the Poisson models are
reported (Chen et al., 2014; Zou, 2004). For the second study of
P. chabaudimortality (Dataset IV) regressions for a mortality outcome
also were used to quantify the differences in mortality between strains.
Both model parameterizations had convergence issues, so the ‘COPY’
was used to facilitate model convergence (Cummings, 2009; Petersen
and Deddens, 2006).6. AS + AT 10 10 50 (18.7–81.3)
7. AS + CB 5 5 40 (5.3–85.3)
8. AJ + AT 10 10 50 (18.7–81.3)
9. AJ + CB 5 5 100 (47.8–100)
10. AT + CB 5 5 80 (28.4–99.5)
11. CW 5 5 0 (0–52.2)
12. AS + CW 5 5 20 (0.51–71.6)
13. AJ + CW 5 5 20 (0.51–71.6)
14. AT + CW 5 5 40 (5.3–85.3)
Total 100 100.0 –
Fig. 2. Kaplan–Meier curves comparing time-to-ﬁrst relapse in single strains and mixed-
strain infections in human challenge experiments with Plasmodium vivax (Dataset I;
N = 66).
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information criteria (AIC/BIC); residuals and standard goodness-of-ﬁt
tests were used to assess adequacy of the robust Poisson and restricted
mean survival models; the ﬁt of the ﬂexible parametric survival model
was judged using overlaid comparisons with Kaplan–Meier curves. ‘Ro-
bust’ (Huber–White) error structure was used in all models to address
the non-independence of subjects within study arms (Williams,
2000). Models were assessed for proportional hazard violations using
Schoenfeld residuals.
All analyses were performed using Stata 13.1 (College Station, TX,
USA) and all tests were two-tailed, with α= 0.05.
3. Results
3.1. P. vivax infections — incubation period
The results from Kaplan–Meier analysis of incubation periods (time
frommosquito exposure to febrile illness; Dataset I) are shown in Fig. 1
and Table 5. Patients infected with the Chesson strain had the shortest
incubation periods, with intermediate (and crossing) curves from
mixed infections, followed by the St. Elizabeth strain infections. The ar-
ithmetic median incubation periods were: Chesson 12 days (95% CI: 12
to 12), mixed infection 14 (12 to 14), and St. Elizabeth 15 (95% CI: 15 to
16), and the differences in restricted mean survival time (RMST) are all
signiﬁcant (mixed infection vs. St. Elizabeth; and Chesson vs. St.
Elizabeth, both p b 0.001; Chesson vs. mixed, p = 0.001).
Comparisons between incidence rate ratios are consistent with the
Kaplan–Meier analysis: infections with the St. Elizabeth strain had an
IRR of 0.80 (95% CI: 0.77–0.83; p b 0.001) relative to the more virulent
Chesson strain. Relative to mixed inoculations, Chesson infections had
an incidence rate ratio (IRR) of 1.1 (1.03–1.15; p b 0.001), with St.
Elizabeth having an IRR of =0.87 (0.82–0.91; p b 0.001). That is, over
the follow-up period, case-patients infected with Chesson parasites
had a ~10% faster rate, and those infected with St. Elizabeth parasites
a ~13% slower rate of events, relative to case-patients infected with
mixed-strain parasites.
3.2. P. vivax infections — relapses
Kaplan–Meier plots for time-to-ﬁrst relapse are shown in Fig. 2.
Rapid times to relapse are apparent in infections with the Chesson
strain, followed by an intermediate curve from mixed inoculations,
with St. Elizabeth relapses having the slowest times-to-relapse, spaced
out over ~10 months. The median uncensored relapse times are:
Chesson, 6.3 weeks (95% CI: 5.6 to 7.1); mixed, 11.4 weeks (9.2 to
38.5); and St. Elizabeth, 41.7 weeks (39.5 to 43.0).
Comparison of the incidence rates for relapses (Table 6) suggests
that relative to the Chesson strain, infections with the St. Elizabeth
strain have an IRR of 0.23 (95% CI: 0.13–0.41, p b 0.001). In comparison
tomixed strain infections, infectionswith the St. Elizabeth strain had an
IRR of 0.44 (0.27–0.70, p = 0.001), while comparison with the Chesson
infections do not achieve signiﬁcance, with an IRR of 1.9 (0.92–3.9; p=
0.081). That is, in single strain infections with St. Elizabeth parasites,
there is ~2.3 fold, and ~4.3 fold, slower rate of relapse relative to
mixed infections and to Chesson strain infections, respectively, while
mixed infections do not show a signiﬁcant difference from infections
with Chesson parasites. Comparison of the RMSTs at t* = 45 weeksTable 5
Comparison of incubation period in human challenge experiments with Plasmodium vivax (Da
Parasite strain Incidence rate ratio, (95% CI)
St. Elizabeth vs. Chesson (ref) 0.80 (0.77–0.83)
Chesson vs. mixed (ref) 1.1 (1.03–1.15)
St. Elizabeth vs. mixed (ref) 0.87 (0.82–0.91)
Note: entries in bold are signiﬁcant with p b 0.05.are signiﬁcant for both St. Elizabeth vs. Chesson (p b 0.001) and vs.
mixed infection (p b 0.001); and the Chesson infections show only a
marginally signiﬁcant difference from mixed strain infections (p =
0.042).
3.3. P. yoelii infections
The results from survival analysis of mortality outcomes in experi-
mental murine P. yoelii infections are shown in Fig. 3. There are clearly
disenable and statistically signiﬁcant differences in the time-to-
mortality between both of the single strains and mixed infections, and
between the two single-strain infections. In Kaplan–Meier analysis,
the Peto–Peto log-rank test indicates signiﬁcant differences between
the strains (‘17X-mild’ vs. ‘17X-virulent’, p = 0.0010; ‘17X-virulent’
vs. mixed, p = 0.0103; ‘17X-mild’ vs. mixed, p = 0.0034); comparison
of the RMST differences (Table 7) at t* = 22 days shows comparable
p-values (‘17X-mild’ vs. ‘17X-virulent’, p b 0.001; ‘17X-virulent’ vs.
mixed, p = 0.002; ‘17X-mild’ vs. mixed, p = b0.001). In ﬂexible para-
metric survival models, with mixed infection as the reference, the
‘17X- virulent’ strain showed a hazard ratio (HR) of 7.5 (95% CI: 1.5 to
38.0; p = 0.015); the ‘17X-mild’ strain had an HR of 0.049 (95% CI:
0.011 to 0.21; p b 0.001). These imply that relative tomixed strain infec-
tions, mild strain infections have ~7.5 times lower risk, and virulent
strain infections have ~20 times greater risk, of mortality in P. yoelii
infections. The incidence rate ratios are also consistent with these
other analyses, and suggest approximately 2-fold faster (vs. virulent)
and 2-fold slower (vs. mild strain) mortality rates in mixed-strain
infections.
3.4. P. chabaudi infections
The analysis of mortality in P. chabaudi data Dataset III is shown in
Table 8. Overall, mixed-strain infections showed a signiﬁcant difference
in risk of mortality relative to single infections: any mixed infections vs.
all single (RR = 1.6; 95% CI: 1.1–2.3, p = 0.009). While mortality was
analyzed within a uniﬁed model for all infections, results are presented
with differing reference categories within each triad (two single infec-
tions and the corresponding mixed infection).taset I; N = 184) (RMST, t* = 18 days).
p-Value, IRR RMST difference (SE) p-Value, RMST
b0.001 3.1 (0.25) 0.001
b0.001 −1.1 (0.34) 0.001
b0.001 2.0 (0.37) b0.001
Table 6
Comparison of time-to-ﬁrst relapse (from parasite inoculation) in human challenge experiments with Plasmodium vivax (Dataset I; N = 66); (RMST, t* = 45 weeks).
Parasite strain Incidence rate ratio, (95% CI) p-Value, IRR RMST difference (SE) p-Value, RMST
St. Elizabeth vs. Chesson (ref) 0.23 (0.13–0.41) b0.001 28.1 (2.8) b0.001
Chesson vs. mixed (ref) 1.9 (0.92–3.9) 0.081 −8.8 (4.4) 0.042
St. Elizabeth vs. mixed (ref) 0.44 (0.27–0.70) 0.001 19.2 (4.3) b0.001
Note: entries in bold are signiﬁcant with p b 0.05.
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direct comparison between the two single strain infections, followed
by comparisons of each single-strain infection to the mixed-strain sce-
nario. In these data, only a single triad shows signiﬁcant differences be-
tween the two ‘pure’ infections; a signiﬁcant difference exists between
single infections with AS (avirulent) and CB (virulent) strains; and the
mixed infection remains signiﬁcantly different from single-strain AS in-
fections (RR = 0.20; 95% CI 0.58–0.70, p = 0.012). However, no evi-
dence for differences was found in comparison with single CB
infections (RR = 0.8; 0.59–1.1, p = 0.162).
Within the second set of P. chabaudi infections (Dataset IV), visual
comparison of the Kaplan–Meier curves suggests complex relationships
between strains (Fig. 4), as shown by the crossing of the survival curves
in many of the infection triads; restricted mean survival times were
used for comparisons.
Overall in this set of experiments, mixed infections showed no
signiﬁcant difference in time-to-mortality from single infections: any
mixed infection vs. all single-strain infections (Peto–Peto test, p =
0.214; RMST difference =−0.5 (SE 0.5), p = 0.356); or in risk of mor-
tality relative to single infections (RR = 1.4; 95% CI: 0.86–2.4, p =
0.168).
Differences between strains of P. chabaudi are shown in Table 9
(dataset IV). As above, we present each infection triad with different
reference groups. Several broad trends are apparent in these results.
Speciﬁcally, in multivariate binary outcome models, mixed infections
are indistinguishable from single infections with a more virulent strain,
and are signiﬁcantly different from single infections with less virulent
strains.
For example, in triad i., a signiﬁcant difference exists between single
infections with AS (avirulent) and AJ (virulent) strains; and the mixed
infection remains signiﬁcantly different from AS infections (RR =
0.0033; 95% CI 0.000092–0.012, p = b0.001). However, no evidence
for a signiﬁcant difference was found when compared with single-
strain AJ infections (RR = 2.3; 95% CI: 0.084–6.5, p = 0.105). While
the RMST differences are consistent with these risk ratios, the Peto–
Peto log-rank tests show similar trends but this does not reach signiﬁ-
cance (p = 0.068). In summary, we ﬁnd that mixed-strain infections
are indistinguishable from the single-strain infections with the moreFig. 3. Kaplan–Meier and ﬂexible-parametric survival model curves comparing time-to-
mortality in single strains and mixed-strain infections in murine challenge experiments
with Plasmodium yoelii (Dataset II; N = 18).virulent strain, but are signiﬁcantly different from single-strain infec-
tions with the less virulent strain, in cases where there are signiﬁcant
differences between the two single-strain infections. It should be
noted that the extremely small reported RRs are due to zero recorded
events in some strain categories. The sole outlier to these trends occurs
in triad vii., which compares two avirulent strains: AS and CW.
Finally, to complement these two separate analyses of P. chabaudi in-
fections, a further comparisonwasmade. All P. chabaudi infections from
both studies (Datasets III/IV) were compared (N = 160) to assess the
overall impact of mixed-strain parasitemia — a limited increase in the
risk of mortality from anymixed-strain infections relative to any having
any single-strain infection was observed (RR = 1.44; 95% CI 1.04–2.01,
p=0.026); as such, infectionwith anymixed parasite population led to
a 44% greater risk of mortality relative to any single-strain infection
across a range of parasite clones with varying virulence.
4. Discussion
4.1. Analytical issues
The results of this analysis provide support for the suggestion that
the relative contribution of each potential component of observed viru-
lence varies substantially during infections in a strain-speciﬁc manner
(Metcalf et al., 2012). Speciﬁcally, the crossing survival curves and ex-
tensive proportional hazard violations imply that the relationships be-
tween the time course and virulence measures varies dramatically
amongst strains, and these effects are evident even when utilizing dif-
ferent metrics for virulence. Moreover, these ﬁndings strongly suggest
that measurement of virulence by any single analysis has the potential
for biases. Dataset II provides a clear example: there is identical mortal-
ity (100%) in the mixed and ‘7-X virulent’ groups, but statistically and
biologically signiﬁcant differences are evident with time-to-event anal-
ysis. Additionally, while the effects are generally consistent across the
analytical approaches, differences do exist across a single triad. For ex-
ample, in triad CW/AT (Table 9) shows signiﬁcant differences when ex-
amining the risk of mortality, but no evidence for differences in the
analysis of time-to-event (RMST) or survival curves (via Peto–Peto
tests).
A second important ﬁnding is quantifying the magnitude of strain
differences. The largest effect sizes between strains in this study are
very biologically signiﬁcant: differences between single strain infections
and infections with mixed-strains using diverse effect measures are
modest-to-large for P. vivax (1.25 times change in risk for incubation;
and 2.3 times risk for relapse), while the maximum for P. yoelii in
Dataset II are much larger (7.5 and 20.1 times the risk). The range
amongst infections with P. chabaudi in Dataset III is more limited rang-
ing from 1.7 to 5 times the risk; while the maximum in Dataset IV is
~600 times change in risk but this limit should be interpreted with cau-
tion due to the small number of outcome events. These effects range
from ‘small’ to ‘very large’ by semi-qualitative standards for biological
relevance; for example one proposed scale: ~1.5, small; ~2.5, medium;
~4, large; and ~10, very large (Maher et al., 2013). The magnitude of
these effects reinforce the potential impact from greater evolutionary
thinking in malaria control, drug policy, and ‘containment’ of resistance
(Havryliuk and Ferreira, 2009; Read et al., 2011).
A third analytical aspect is a detailed consideration of the shape of
the survival curves in this analysis. In the ecological and demographic
Table 7
Comparison of time-to-mortality in murine challenge experiments with Plasmodium yoelii (RMST, t* = 22 days) (Dataset II; N = 18).
Parasite strain p-value, Peto–Peto
test
RMST difference
(SE)
p-value,
RMST
IRR (95% CI) p-value,
IRR
Hazard ratio (95% CI) p-value, hazard
ratio
‘17X-mild’ vs. ‘17X-virulent’ (ref) 0.0010 14.9 (1.3) b0.001 0.51 (0.36–0.72) b0.001 0.0065 (0.00091–0.046) b0.001
‘17X-virulent’ vs. mixed (ref) 0.0103 −4.8 (1.6) 0.002 1.96 (1.39–2.76) b0.001 7.51 (1.49–37.87) 0.015
‘17X-mild’ vs. mixed (ref) 0.0034 10.0 (1.9) b0.001 0.23 (0.075–0.14) 0. 004 0.049 (0.011–0.21) b0.001
Note: entries in bold are signiﬁcant with p b 0.05. IRR = incidence rate ratio.
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ship curves,’ allow populations to be categorized into three idealized
life courses (referred to as type I, II and III curves) (Pianka, 2011); see
Fig. 5. Type III curves are categorized by a large number of mortality
events early in the time course; type II by a relatively constant rate of
events; and type I by generally low ‘failure’ rate until the oldest age
classes.
Examination of the survival curves within this study (especially
P. yoelii) and Fig. 1 (with allowances for the crossing curves) closely
mimics these classes of survivorship curves, although the underlying
mechanisms are unrelated. We suggest that future studies should con-
sider this general scheme for classiﬁcation of virulence for two reasons.
First, it allows examination for study population-level effects and
‘smooths-out’ individual-level variation in response. Secondly, it sum-
marizes the complex interplay between host and parasites to more
comprehensively capture the composite endpoint of ‘virulence.’ Finally,
several different metrics have been suggested to allow quantitative
comparisons between the convexity of survivorship curves, and have
potentially important utility in directly classifying and comparing the
virulence of parasite populations (Anson, 2002).
4.2. Concordance between studies and potential drivers of virulence
Early studies included a small set of parasite co-inoculations in
neurosyphilis patients (Boyd et al., 1941, 1938) which suggested that
co-inoculation led delayed parasite clearance, and impaired acquisition
of immunity to either strain as assessed by subsequent re-infections;
however, no direct measures of virulence were reported.
The authors of the original study with mixed P. vivax inoculations
(dataset I) in human populations analyzed in this work concluded that
within wide individual variation, the overall pattern of all recorded re-
lapses in mixed-strain infections was a combination of the two strain-Table 8
Comparison of risk ratios from binomialmodels for mortality inmixed infection by strains
in murine challenge experiments with Plasmodium chabaudi (Dataset III; N = 60).
Parasite strain triad
(more virulent strains in
bold)
Comparison Risk ratio (95%
CI)
p-value,
risk
ratio
i. Mixed AS/CB (ref) AS vs. CB
(ref)
0.25 (0.069–0.91) 0.035
AS vs. AS +
CB (ref)
0.20 (0.58–0.70) 0.012
CB vs. AS +
CB (ref)
0.80 (0.59–1.1) 0.162
ii. Mixed DS/CB (ref) DS vs. CB
(ref)
0.75 (0.41–1.4) 0.346
DS vs. DS +
CB (ref)
0.60 (0.36–0.99) 0.050
CB vs. DS +
CB (ref)
0.80 (0.59–1.1) 0.162
iii. Mixed AS/DS (ref) AS vs. DS
(ref)
0.33 (0.09–1.3) 0.111
AS vs. AS +
DS (ref)
0.33 (0.09–1.3) 0.111
DS vs. AS +
DS (ref)
1.0 (0.49–2.1) 1.0
Note: entries in bold are signiﬁcant with p b 0.05.speciﬁc responses; however, these conclusions were based solely on a
qualitative assessment of the overall respective clinical courses; incuba-
tion period was not considered (Cooper et al., 1950).
We ﬁnd that the incubation period shows signiﬁcant differences be-
tween the mixed and each single-strain infection. Consideration of the
time-to-ﬁrst relapse, however, suggests that themixed strain infections
are only marginally different (RMST analysis) or indistinguishable (IRR
analysis) from single-strain infections with the virulent Chesson strain.
Although poorly understood, hypnozoite re-activation is a different bio-
logical process from incubation (Markus, 2012), so the results from the
relapse analysis may not be directly comparable to other measures of
virulence.
Qualitative comparison of the survival curves in Fig. 2 suggests that
the earlier portion of the mixed-infection curve more closely follows,
but is not equivalent to, that of Chesson strain infections. However, we
are unable to differentiate between two potential mechanisms: coordi-
nated relapse between genetically diverse hypnozoites, or simply the
ﬁrst result of having two superimposed hypnozoite relapse curves.
Consensus about clonal diversity within relapses has been elusive
(Imwong et al., 2012, 2007), and conclusions may be highly dependent
on the speciﬁc probes used to compare parasite-relatedness (Restrepo
et al., 2011); however, it is clear that some parasite sub-populations
that are more prone to relapse, and that there is extensive diversity in
parasite populations (Battle et al., 2014; Lin et al., 2012; Lover and
Coker, 2013). Critically, relapse epidemiology has been highlighted as
a key gap in control of this parasite (Ferreira et al., 2007; Havryliuk
and Ferreira, 2009).
In discussion of themixed murine P. yoelii infections (Dataset II) the
original study authors note that while the mild strain preferentially in-
fected only reticulocytes even in fatal outcomes, and the virulent form
‘overwhelmingly’ infected mature erythrocytes, mixed infections ini-
tially showed parasitemias in both RBC stages, which then progressed
in the four surviving animals to be predominately composed of infected
reticulocytes (Hargreaves et al., 1975). Our results quantify the size of
these differences, and ﬁnding an intermediate survival curve in
mixed-strain infections provides further support for these hematologi-
cal observations.
Earlier work using P. chabaudi found greater virulence in mixed-
strain infections relative to single clone infections, as measured by
weight loss and RBC count (anemia level) (Taylor et al., 1998). Our anal-
yses of P. chabaudi data do not show a signiﬁcant difference inmortality
betweenmixed infections and all single strains in these data, but this is
potentially due to the range of parasite clones examined. Moreover, our
results suggest that within these parasite lineages, RBC and weight loss
metrics may only capture a portion of the complexity in the measure-
ment of ‘virulence’; within parasite triads, we ﬁnd mortality in mixed-
strain infections is not increased, but equivalent to mortality in
infections with the more virulent strain in P. chabaudi infections. In
examination of the strains that appear in both P. chabaudi studies (AS/
CB; datasets III/IV) it is noteworthy thatwhile the direction of the effects
is consistent, the size of the risk ratios differs by ~100-fold. While many
experimental differences are evident (different laboratories and mouse
strains, decades apart) these differences are remarkably consistent
with the inocula (104 vs. 106 parasitized erythrocytes). The broad con-
sistency of effect sizes between strains in the other experiment in this
analysis (including mosquito-transmitted infections) could indicate
Fig. 4.Kaplan–Meier curves comparing time-to-mortality in single strains andmixed-strain infections inmurine challenge experiments with Plasmodium chabaudi (Dataset IV; N= 100).
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parasite dynamics.
Our results reconcile these P. chabaudi experiments withmathemat-
icalmodels that have suggested that hostmortality is strongly driven by
the more virulent strain within an infection (Alizon and van Baalen,
2008), but suggest the existence of a fundamental limit. Comparison
of the risk ratios between the CB/AS triad (RR = 2.5) and all mixed/
pure infections (RR = 1.44) amongst all studied strains, supports the
ﬁndings of Alizon which suggest that the antigenic distance between
strains has critical impacts on observed virulence (Alizon and van
Baalen, 2008). These mathematical models suggest that there may be
a ‘sweet-spot’ where maximum competition occurs — if strains are
highly antigenically divergent, they can parasitize essentially indepen-
dent niches in the host with subsequent limited need for competition;
whereas highly related parasites are too similar to be differentiated by
general immune responses. The overall comparisons of single-strains
as survival curves or as RR in these studies provide generally consistent
results with those from comprehensive models of propagation number
in studies with many of the same P. chabaudi strains (Metcalf et al.,
2012).
In our analysis of the much larger set of experiments using
P. chabaudi we ﬁnd greater nuances in interactions between strains,
andwe ﬁnd that mortality and time-to-event inmixed-strain infections
are both indistinguishable from those of virulent-strain single infections.
This is in sharp contrast to the results from P. yoelii experiments, with
similar triad-wise sample sizes. One potential explanation for thesedifferences comes from differential blood cell preferences: P. vivax
and P. yoelii generally infect the youngest RBC stages (reticulocytes)
(McKenzie et al., 2002),whereas P. chabaudi (like P. falciparum) has lim-
ited speciﬁcity, and readily infects both reticulocytes and normocytes
(Snounou et al., 1992). These results concur with those from modeling
studies that explicitlymodeled the impact of age-structured erythrocyte
susceptibility; the authors concluded that while this clearly is an impor-
tant modulator of parasite dynamics, more research into these effects
should be a priority (McQueen and McKenzie, 2004).
These divergent dynamics reinforce the suggestion that virulence
has different underlying mechanisms in P. vivax-like and P. falciparum-
like parasites (Wassmer et al., 2015). This hypothesis is consistent
with data suggesting that immunity and RBC dynamics, which differ
greatly between the parasite ‘types,’ are both important contributors
to competitive ability and parasite dynamics. This suggests that
maximal competitive advantage may have a fundamental limit, driven
primarily by limited numbers of susceptible RBCs in P. vivax-type in-
fections, so virulent strains can only out-compete to a certain extent,
but other interrelated factors may also play an important role (Alizon
et al., 2009). However, other studies with P. chabaudi reached differing
conclusions and suggest the evolutionary trajectory of higher-
virulence strainswithin amixed-strain infection are primarily impacted
by burst size (number of progeny per merozoite) plus differential inter-
actions with host immunity (Mideo et al., 2011). The complexity of the
interplay between these factors was observed in observational studies
of avian infections, where wild-caught specimens with mixed-strain
Table 9
Comparison of Kaplan–Meier estimator, restricted mean survival times, and risk ratios from binomial models for mortality inmixed infection by strains inmurine challenge experiments
with Plasmodium chabaudi (Dataset IV; N = 100); (RMST, t* = 15 days).
Parasite strain triad
(more virulent strains in bold)
Comparison p-value,
Peto–Peto test
RMST difference
(SE)
p-Value RMST
difference
Risk ratio (95% CI) p-value,
risk ratio
i. Mixed AS/AJ AS vs. AJ (ref) 0.0015 3.4 (0.84) b0.001 0.0015 (0.00054–0.0038) b0.001
AS vs. AS + AJ (ref) 0.0679 1.4 (0.71) 0.049 0.0033 (0.00092–0.012) b0.001
AJ vs. AS + AJ (ref) 0.0792 −2.0 (1.1) 0.070 2.32 (0.84–6.5) 0.105
ii. Mixed AS/AT AS vs. AT (ref) 0.0685 1.9 (0.93) 0.041 0.0033 (0.00091–0.012) b0.001
AS vs. AS + AT (ref) 0.0130 1.6 (0.89) 0.072 0.0020 (0.00068–0.0059) b0.001
AT vs. AS + AT (ref) 0.5584 −0.30 (1.3) 0.816 0.61 (0.19–1.88) 0.381
iii. Mixed AS/CB AS vs. CB (ref) 0.0062 3.0 (1.2) 0.012 0.0018 (0.00054–0.0056) b0.001
AS vs. AS + CB (ref) 0.0350 1.4 (0.94) 0.145 0.0026 (0.00063–0.011) b0.001
CB vs. AS + CB (ref) 0.3547 −1.6 (1.4) 0.266 1.50 (0.41–5.5) 0.539
iv. Mixed AJ/AT AJ vs. AT (ref) 0.1933 −1.5 (1.3) 0.232 2.32 (0.83–6.55) 0.109
AJ vs. AJ + AT (ref) 0.4769 −0.90 (1.2) 0.463 1.40 (0.67–2.9) 0.371
AT vs. AJ + AT (ref) 0.5080 0.60 (1.3) 0.641 0.61 (0.19–1.9) 0.379
v. Mixed AJ/CB AJ vs. CB (ref) na −0.43 (1.4) 0.762 1.2 (0.52–2.86) 0.652
AJ vs. AJ + CB (ref) 0.2534 1.6 (1.3) 0.222 0.74 (0.45–1.2) 0.184
CB vs. AJ + CB (ref) 0.1293 2.0 (1.5) 0.176 0.60 (0.30–1.2) 0.163
vi. Mixed AT/CB AT vs. CB (ref) na 1.1 (1.5) 0.470 0.52 (0.16–1.7) 0.290
AT vs. AT + CB (ref) 0.1245 2.5 (1.5) 0.099 0.39 (0.14–1.1) 0.084
CB vs. AT + CB (ref) 0.3602 1.4 (1.6) 0.388 0.75 (0.32–1.7) 0.503
vii. Mixed AS/CW AS vs. CW (ref) 0.1573 0.33 (0.32) 0.917 0.06 (0.20–4.5) 0.955
AS vs. AS + CW (ref) 0.1573 1.0 (0.95) 0.279 0.0048 (0.00066–0.035) b0.001
CW vs. AS + CW (ref) 0.3173 1.0 (0.90) 0.266 0.0050 (0.00058–0.043) b0.001
viii. Mixed CW/AJ CW vs AJ (ref) 0.0230 3.4 (0.93) b0.001 0.0015 (0.00039–0.0057) b0.001
CW vs. CW + AJ (ref) 0.3173 1.4 (1.3) 0.266 0.0050 (0.00058–0.043) b0.001
AJ vs. CW + AJ (ref) na −2.0 (1.6) 0.209 3.3 (0.54–20.7) 0.196
ix. Mixed CW/AT CW vs. AT (ref) 0.1952 1.9 (1.1) 0.067 0.0035 (0.00070–0.017) b0.001
CW vs. CW + AT (ref) 0.1360 2.2 (1.2) 0.071 0.0050 (0.00058–0.043) b0.001
AT vs. CW + AT (ref) na 0.33 (1.6) 0.084 1.4 (0.19–10.9) 0.729
Notes: (RMST, at t* = 15 days); entries in bold are signiﬁcant with p b 0.05; ‘na’ signiﬁes that test is not applicable due to crossing survival curves.
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ductive success (Marzal et al., 2008).
In spite of analytical limitations in these data, our results suggest that
general virulence proxies or singlemethodologiesmay fail to capture all
facets of observed virulence, and a broader selection of endpoints and
methods should be considered in analyses.
4.3. Limitations
The P. vivax and P. yoelii studies are based on analysis of secondary
data with limited experimental detail reported. Additionally, the
murine experiments used blood-transfer via syringe and not infected
vectors, which has the potential to impact parasite dynamics
(Nkhoma et al., 2012; Paul et al., 2004) and studies have suggested
that parasite passage through anopheline vectors can modulate viru-
lence (Spence et al., 2013). Therefore syringe-induced infections likely
represent extremes in virulence that may not reﬂect natural dynamics
(Mideo et al., 2011). Lastly, many of the comparisons in the murine
models were made using a small number of animals per treatmentFig. 5. Idealized ecological/demographic survivorship curves.group, and not ﬁnding an effect in some groups may be due to sample
size limitations.
5. Conclusions
These results link human andmurine experimental studies, and also
provide further evidence for differing dynamics between malaria
species dependent on blood-stage cell speciﬁcities. These ‘slippages’
suggest research areas that could provide important insights into
intra-host malaria dynamics, and should be prioritized in planning
new murine challenge studies. Our results suggest at least some of
these conﬂicting results could be partially addressed by consideration
of a more diverse set of endpoints beyond comparisons of mean anemia
or parasitemia between groups and the use of effect size measures as
opposed to p-values of signiﬁcance. While constrained by crossing
curves and zero-event categories, our analyses suggest a potential for
fuller use of data that could maximize the utility of these complex and
experimentally demanding experiments.
While virulence management has been highlighted as a potential
key contribution from evolutionary biology especially in malaria, this
paradigm has had limited impact on clinical or epidemiological practice
(Restif, 2009). The effect sizes measured between single strain and
mixed-strain inoculations in these studies are highly biologically signif-
icantwithmagnitudes that are well within the ‘important’ range for ep-
idemiological studies; these ﬁnding reinforce the importance of greater
consideration of evolutionary epidemiology in malaria control.
While the inherent limitations of these model systems in other host
species have been recognized, they provide invaluable insight into par-
asite evolutionary dynamics within a host, and a recent comprehensive
review concluded that there needs to be closer linkages between
human studies and animal models to allow the development of truly
synergistic research programs (Langhorne et al., 2011).
Finally, these results reinforce that evolutionary drivers of strain
competition and virulence differ in fundamental ways between
P. vivax and P. falciparum. This suggests several broad avenues for future
90 A.A. Lover, R.J. Coker / Infection, Genetics and Evolution 36 (2015) 82–91animal models. A head-to-head comparison within the same laboratory
between reticulocyte-speciﬁc and generalist parasites encompassing
similar differences in virulence could provide important insights into
virulence and parasite evolution. These results could be of critical
importance for the planning of species-speciﬁc policies for drug-
resistance mitigation, and towards global malaria elimination for all
malaria species.Acknowledgments
We are grateful to the Read group for their sharing of the P. chabaudi
data, and to an anonymous reviewer whose input greatly strengthened
this work.
Competing interests
The authors declare that they have no competing interests.
Financial support
None to report.
Authors' contributions
AAL envisioned the study, collected and analyzed all data, andwrote
the ﬁrst draft; RJC supervised throughout and edited the drafts.References
Alizon, S., van Baalen, M., 2008. Multiple infections, immune dynamics, and the evolution
of virulence. Am. Nat. 172, e150–e168. http://dx.doi.org/10.1086/590958.
Alizon, S., Hurford, A., Mideo, N., van Baalen, M., 2009. Virulence evolution and the trade-
off hypothesis: history, current state of affairs and the future. J. Evol. Biol. 22,
245–259. http://dx.doi.org/10.1111/j.1420-9101.2008.01658.x.
Alizon, S., Luciani, F., Regoes, R.R., 2011. Epidemiological and clinical consequences of
within-host evolution. Trends Microbiol. 19, 24–32. http://dx.doi.org/10.1016/j.tim.
2010.09.005.
Alizon, S., de Roode, J.C., Michalakis, Y., 2013. Multiple infections and the evolution of vir-
ulence. Ecol. Lett. 16, 556–567. http://dx.doi.org/10.1111/ele.12076.
Andersen, P.K., Perme, M.P., 2010. Pseudo-observations in survival analysis. Stat. Methods
Med. Res. 19, 71–99. http://dx.doi.org/10.1177/0962280209105020.
Anson, J., 2002. Of entropies and inequalities: Summary measures of the age distribution
of mortality. In: Duchene, J., Wunsch, G., Mouchart, M. (Eds.), The Life Table: Model-
ling Survival and Death, European Studies of Population. Springer, Dordrecht.
Balmer, O., Tanner, M., 2011. Prevalence and implications of multiple-strain infections.
Lancet Infect. Dis. 11, 868–878. http://dx.doi.org/10.1016/S1473-3099(11)70241-9.
Barclay, V.C., Kennedy, D.A., Weaver, V.C., Sim, D., Lloyd-Smith, J.O., Read, A.F., 2014. The
effect of immunodeﬁciency on the evolution of virulence: an experimental test
with the rodent malaria Plasmodium chabaudi. Am. Nat. 184, S47–S57. http://dx.doi.
org/10.1086/676887.
Battle, K.E., Karhunen, M.S., Bhatt, S., Gething, P.W., Howes, R.E., Golding, N., Boeckel,
T.P.V., Messina, J.P., Shanks, G.D., Smith, D.L., Baird, J.K., Hay, S.I., 2014. Geographical
variation in Plasmodium vivax relapse. Malar. J. 13, 144. http://dx.doi.org/10.1186/
1475-2875-13-144.
Bell, A.S., Roode, De., Sim, J.C., Read, D., A.F., 2006. Within-host competition in genetically
diverse malaria infections: parasite virulence and competitive success. Evolution 60,
1358–1371. http://dx.doi.org/10.1111/j.0014-3820.2006.tb01215.x.
Bell, A.S., de Roode, J.C., Sim, D.G., Read, A.F., 2014. Data From:Within-host Competition in
Genetically Diverse Malaria Infections: Parasite Virulence and Competitive Success
(Dryad Digital Repository). http://dx.doi.org/10.5061/dryad.bv188.
Bordes, F., Morand, S., 2009. Parasite diversity: an overlooked metric of parasite pres-
sures? Oikos 118, 801–806. http://dx.doi.org/10.1111/j.1600-0706.2008.17169.x.
Boyd, M.F., Kupper, W.H., Matthews, C.B., 1938. A deﬁcient homologous immunity follow-
ing simultaneous inoculation with two strains of Plasmodium vivax. Am. J. Trop. Med
521–524 (s1-18).
Boyd, M.F., Kitchen, S.F., Matthews, C.B., 1941. On the natural transmission of infection
from patients concurrently infected with two strains of Plasmodium vivax. Am.
J. Trop. Med. 645–652 (s1-21).
Casadevall, A., Pirofski, L., 2001. Host‐pathogen interactions: the attributes of virulence.
J. Infect. Dis. 184, 337–344. http://dx.doi.org/10.1086/322044.
Chen, W., Shi, J., Qian, L., Azen, S.P., 2014. Comparison of robustness to outliers between
robust Poisson models and log-binomial models when estimating relative risks for
common binary outcomes: a simulation study. BMC Med. Res. Methodol. 14, 82.
http://dx.doi.org/10.1186/1471-2288-14-82.
Collins, W., 2013. Origin of the St. Elizabeth strain of Plasmodium vivax. Am. J. Trop. Med.
Hyg. 88, 726-726. http://dx.doi.org/10.4269/ajtmh.12-0351.
Cooper,W.C., Coatney, G.R., Culwell,W.B., Eyles, D.E., Young, M.D., 1950. Studies in human
malaria XXVI. Simultaneous infection with the Chesson and the St. Elizabeth strains
of Plasmodium vivax. J. Natl. Malar. Soc. 9, 187–190.
Cummings, P., 2009. Methods for estimating adjusted risk ratios. Stata J. 9, 175–196.
Day, T., 2002. On the evolution of virulence and the relationship between various mea-
sures of mortality. Proc. R. Soc. Lond. B Biol. Sci. 269, 1317–1323. http://dx.doi.org/
10.1098/rspb.2002.2021.de Araujo, F.C.F., de Rezende, A.M., Fontes, C.J.F., Carvalho, L.H., Alves de Brito, C.F., 2012.
Multiple-clone activation of hypnozoites is the leading cause of relapse in Plasmodium
vivax infection. PLoS ONE 7, e49871. http://dx.doi.org/10.1371/journal.pone.0049871.
de Roode, J.C., Pansini, R., Cheesman, S.J., Helinski, M.E.H., Huijben, S., Wargo, A.R., Bell,
A.S., Chan, B.H.K., Walliker, D., Read, A.F., 2005. Virulence and competitive ability in
genetically diverse malaria infections. Proc. Natl. Acad. Sci. 102, 7624–7628. http://
dx.doi.org/10.1073/pnas.0500078102.
Ferreira, M.U., Karunaweera, N.D., da Silva-Nunes, M., da Silva, N.S., Wirth, D.F., Hartl, D.L.,
2007. Population structure and transmission dynamics of Plasmodium vivax in rural
Amazonia. J. Infect. Dis. 195, 1218–1226.
Harcourt, B.E., 2011. Making willing bodies: the University of Chicago human experi-
ments at Stateville Penitentiary. Soc. Res. 78, 443–478.
Hargreaves, J., Yoeli, M., Nussenzweig, R.S., 1975. Immunological studies in rodent malar-
ia. I: protective immunity induced inmice bymild strains of Plasmodium berghei yoelii
against a virulent and fatal line of this Plasmodium. Ann. Trop. Med. Parasitol. 69,
289–299.
Havryliuk, T., Ferreira, M.U., 2009. A closer look at multiple-clone Plasmodium vivax infec-
tions: detection methods, prevalence and consequences. Mem. Inst. Oswaldo Cruz
104, 67–73.
Henry-Halldin, C.N., Sepe, D., Susapu, M., McNamara, D.T., Bockarie, M., King, C.L.,
Zimmerman, P.A., 2011. High-throughput molecular diagnosis of circumsporozoite
variants VK210 and VK247 detects complex Plasmodium vivax infections in malaria
endemic populations in Papua New Guinea. Infect. Genet. Evol. 11, 391–398. http://
dx.doi.org/10.1016/j.meegid.2010.11.010.
Imwong, M., Snounou, G., Pukrittayakamee, S., Tanomsing, N., Kim, J.R., Nandy, A.,
Guthmann, J.-P., Nosten, F., Carlton, J., Looareesuwan, S., Nair, S., Sudimack, D., Day,
N.P.J., Anderson, T.J.C., White, N.J., 2007. Relapses of Plasmodium vivax infection usu-
ally result from activation of heterologous hypnozoites. J. Infect. Dis. 195, 927–933.
http://dx.doi.org/10.1086/512241.
Imwong, M., Boel, M.E., Pagornrat, W., Pimanpanarak, M., McGready, R., Day, N.P.J., Nosten,
F., White, N.J., 2012. The ﬁrst Plasmodium vivax relapses of life are usually genetically
homologous. J. Infect. Dis. 205, 680–683. http://dx.doi.org/10.1093/infdis/jir806.
Juliano, J.J., Porter, K., Mwapasa, V., Sem, R., Rogers, W.O., Ariey, F., Wongsrichanalai,
C., Read, A., Meshnick, S.R., 2010. Exposing malaria in-host diversity and estimat-
ing population diversity by capture-recapture using massively parallel pyrose-
quencing. Proc. Natl. Acad. Sci. 107, 20138–20143. http://dx.doi.org/10.1073/
pnas.1007068107.
Killick-Kendrick, R., 1974. Parasitic protozoa of the blood of rodents: a revision of Plasmodi-
um berghei. Parasitology 69, 225–237. http://dx.doi.org/10.1017/S0031182000048071.
Klein, M., Kleinbaum, D.G., 2005. Survival Analysis. 2nd ed. Springer Science + Business
Media, Inc., New York.
Lachin, J.M., 2011. Biostatistical Methods the Assessment of Relative Risks. Wiley,
Hoboken, N.J.
Langhorne, J., Buffet, P., Galinski, M., Good, M., Harty, J., Leroy, D., Mota, M.M., Pasini, E.,
Renia, L., Riley, E., Stins, M., Duffy, P., 2011. The relevance of non-human primate
and rodent malaria models for humans. Malar. J. 10, 23. http://dx.doi.org/10.1186/
1475-2875-10-23.
Li, H., Han, D., Hou, Y., Chen, H., Chen, Z., 2015. Statistical inferencemethods for two cross-
ing survival curves: a comparison of methods. PLoS ONE 10. http://dx.doi.org/10.
1371/journal.pone.0116774.
Lin, J.T., Juliano, J.J., Kharabora, O., Sem, R., Lin, F.-C., Muth, S., Ménard, D., Wongsrichanalai,
C., Rogers, W.O., Meshnick, S.R., 2012. Individual Plasmodium vivax msp1 variants
within polyclonal P. vivax infections display different propensities for relapse.
J. Clin. Microbiol. 50, 1449–1451. http://dx.doi.org/10.1128/JCM.06212-11.
Lover, A.A., Coker, R.J., 2013. Quantifying effect of geographic location on epidemiology of
Plasmodium vivax malaria. Emerg. Infect. Dis. 19, 1058–1065. http://dx.doi.org/10.
3201/eid1907.121674.
Mackinnon, M.J., Read, A.F., 2004. Virulence in malaria: an evolutionary viewpoint. Philos.
Trans. R. Soc. Lond. B Biol. Sci. 359, 965–986. http://dx.doi.org/10.1098/rstb.2003.1414.
Maher, J.M., Markey, J.C., Ebert-May, D., 2013. The other half of the story: effect size
analysis in quantitative research. Cell Biol. Educ. 12, 345–351. http://dx.doi.org/10.
1187/cbe.13-04-0082.
Markus, M.B., 2012. Dormancy in mammalianmalaria. Trends Parasitol. 28, 39–45. http://
dx.doi.org/10.1016/j.pt.2011.10.005.
Marzal, A., Bensch, S., Reviriego, M., Balbontin, J., De Lope, F., 2008. Effects of malaria
double infection in birds: one plus one is not two. J. Evol. Biol. 21, 979–987. http://
dx.doi.org/10.1111/j.1420-9101.2008.01545.x.
McKenzie, F.E., Jeffery, G.M., Collins, W.E., 2002. Plasmodium vivax blood-stage dynamics.
J. Parasitol. 88, 521–535.
McKenzie, F.E., Smith, D.L., O'Meara, W.P., Riley, E.M., 2008. Strain theory of malaria:
the ﬁrst 50 years. Adv. Parasitol. 66, 1–46. http://dx.doi.org/10.1016/S0065-
308X(08)00201-7.
McQueen, P.G., McKenzie, F.E., 2004. Age-structured red blood cell susceptibility and the
dynamics of malaria infections. Proc. Natl. Acad. Sci. 101, 9161–9166. http://dx.doi.
org/10.1073/pnas.0308256101.
Metcalf, C.J.E., Graham, A.L., Huijben, S., Barclay, V.C., Long, G.H., Grenfell, B.T., Read, A.F.,
Bjørnstad, O.N., 2011. Partitioning regulatory mechanisms of within-host malaria dy-
namics using the effective propagation number. Science 333, 984–988. http://dx.doi.
org/10.1126/science.1204588.
Metcalf, C.J.E., Long, G.H., Mideo, N., Forester, J.D., Bjornstad, O.N., Graham, A.L., 2012. Re-
vealing mechanisms underlying variation in malaria virulence: effective propagation
and host control of uninfected red blood cell supply. J. R. Soc. Interface 9, 2804–2813.
http://dx.doi.org/10.1098/rsif.2012.0340.
Mideo, N., Savill, N.J., Chadwick, W., Schneider, P., Read, A.F., Day, T., Reece, S.E., 2011.
Causes of variation in malaria infection dynamics: insights from theory and data.
Am. Nat. 178, E174–E188. http://dx.doi.org/10.1086/662670.
91A.A. Lover, R.J. Coker / Infection, Genetics and Evolution 36 (2015) 82–91Nakagawa, S., Cuthill, I.C., 2007. Effect size, conﬁdence interval and statistical signiﬁcance:
a practical guide for biologists. Biol. Rev. 82, 591–605. http://dx.doi.org/10.1111/j.
1469-185X.2007.00027.x.
Nkhoma, S.C., Nair, S., Cheeseman, I.H., Rohr-Allegrini, C., Singlam, S., Nosten, F., Anderson,
T.J.C., 2012. Close kinship within multiple-genotype malaria parasite infections. Proc.
R. Soc. B Biol. Sci. 279, 2589–2598. http://dx.doi.org/10.1098/rspb.2012.0113.
Parner, E.T., Andersen, P.K., 2010. Regression analysis of censored data using pseudo-
observations. Stata J. 10, 408–422.
Paul, R.E., Diallo, M., Brey, P.T., 2004. Mosquitoes and transmission of malaria parasites —
not just vectors. Malar. J. 3, 39. http://dx.doi.org/10.1186/1475-2875-3-39.
Perkins, S.L., Sarkar, I.N., Carter, R., 2007. The phylogeny of rodent malaria parasites: si-
multaneous analysis across three genomes. Infect. Genet. Evol. 7, 74–83. http://dx.
doi.org/10.1016/j.meegid.2006.04.005.
Petersen, M.R., Deddens, J.A., 2006. Letter: easy SAS calculations for risk or prevalence ra-
tios and differences. Am. J. Epidemiol. 163, 1158–1159.
Pianka, E.R., 2011. Evolutionary Ecology. Eric R, Pianka.
Poulin, R., Combes, C., 1999. The concept of virulence: interpretations and implications.
Parasitol. Today 15, 474–475. http://dx.doi.org/10.1016/S0169-4758(99)01554-9.
Read, A.F., Day, T., Huijben, S., 2011. The evolution of drug resistance and the curious or-
thodoxy of aggressive chemotherapy. Proc. Natl. Acad. Sci. 108, 10871–10877. http://
dx.doi.org/10.1073/pnas.1100299108.
Restif, O., 2009. Evolutionary epidemiology 20 years on: challenges and prospects. Infect.
Genet. Evol. 9, 108–123. http://dx.doi.org/10.1016/j.meegid.2008.09.007.
Restif, O., Hayman, D.T.S., Pulliam, J.R.C., Plowright, R.K., George, D.B., Luis, A.D.,
Cunningham, A.A., Bowen, R.A., Fooks, A.R., O'Shea, T.J., Wood, J.L.N., Webb, C.T.,
2012. Model-guided ﬁeldwork: practical guidelines for multidisciplinary research
on wildlife ecological and epidemiological dynamics. Ecol. Lett. http://dx.doi.org/10.
1111/j.1461-0248.2012.01836.x.
Restrepo, E., Imwong, M., Rojas, W., Carmona-Fonseca, J., Maestre, A., 2011. High genetic
polymorphism of relapsing P. vivax isolates in northwest Colombia. Acta Trop. 119,
23–29. http://dx.doi.org/10.1016/j.actatropica.2011.03.012.
Rigaud, T., Perrot-Minnot, M.-J., Brown, M.J.F., 2010. Parasite and host assemblages: embrac-
ing the reality will improve our knowledge of parasite transmission and virulence. Proc.
R. Soc. B Biol. Sci. 277, 3693–3702. http://dx.doi.org/10.1098/rspb.2010.1163.
Rothman, K.J., Greenland, S., Lash, T.L., 2008. Modern Epidemiology. Third. ed. Lippincott
Williams & Wilkins, Philadelphia.Royston, P., Lambert, P.C., 2011. Flexible Parametric Survival Analysis Using Stata: Beyond
the Cox Model. 1st ed. Stata Press, College Station, Texas.
Royston, P., Parmar, M.K.B., 2002. Flexible parametric proportional-hazards and
proportional-odds models for censored survival data, with application to prognostic
modelling and estimation of treatment effects. Stat. Med. 21, 2175–2197. http://dx.
doi.org/10.1002/sim.1203.
Royston, P., Parmar, M.K.B., 2011. The use of restrictedmean survival time to estimate the
treatment effect in randomized clinical trials when the proportional hazards assump-
tion is in doubt. Stat. Med. 30, 2409–2421. http://dx.doi.org/10.1002/sim.4274.
Snounou, G., Bourne, T., Jarra, W., Viriyakosol, S., Wood, J.C., Brown, K.N., 1992. Assess-
ment of parasite population dynamics in mixed infections of rodent plasmodia. Par-
asitology 105, 363–374. http://dx.doi.org/10.1017/S0031182000074539.
Spence, P.J., Jarra, W., Lévy, P., Reid, A.J., Chappell, L., Brugat, T., Sanders, M., Berriman, M.,
Langhorne, J., 2013. Vector transmission regulates immune control of Plasmodium vir-
ulence. Nature 498, 228–231. http://dx.doi.org/10.1038/nature12231.
Taylor, L.H., Mackinnon, M.J., Read, A.F., 1998. Virulence of mixed-clone and single-clone
infections of the rodent malaria Plasmodium chabaudi. Evolution 583–591.
Ungureanu, E., Killick-Kendrick, R., Garnham, P.C.C., Branzei, P., Romanescu, C.,
Shute, P.G., 1976. Prepatent periods of a tropical strain of Plasmodium vivax
after inoculations of tenfold dilutions of sporozoites. Trans. R. Soc. Trop. Med.
Hyg. 70, 482–483.
Wassmer, S.C., Taylor, T.E., Rathod, P.K., Mishra, S.K., Mohanty, S., Arevalo-Herrera, M.,
Duraisingh, M.T., Smith, J.D., 2015. Investigating the pathogenesis of severe malaria:
a multidisciplinary and cross-geographical approach. Am. J. Trop. Med. Hyg. http://
dx.doi.org/10.4269/ajtmh.14-0841 (in press).
Weijer, C., 1999. Another Tuskegee? Am. J. Trop. Med. Hyg. 61, 1–3.
Williams, R.L., 2000. A note on robust variance estimation for cluster-correlated data. Bio-
metrics 56, 645–646.
World Health Organization, 2014. World Malaria Report 2014. World Health Organiza-
tion, Geneva.
Zimmerman, P.A., Mehlotra, R.K., Kasehagen, L.J., Kazura, J.W., 2004. Why do we need to
knowmore about mixed Plasmodium species infections in humans? Trends Parasitol.
20, 440–447. http://dx.doi.org/10.1016/j.pt.2004.07.004.
Zou, G., 2004. A modiﬁed Poisson regression approach to prospective studies with binary
data. Am. J. Epidemiol. 159, 702–706. http://dx.doi.org/10.1093/aje/kwh090.
